Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 80Squamous Cell Carcinoma of Head and Neck 44Lung Neoplasms 36Urinary Bladder Neoplasms 22Oropharyngeal Neoplasms 22Head and Neck Neoplasms 19Nasopharyngeal Carcinoma 18Carcinoma 16Parkinson Disease 4, Autosomal Dominant Lewy Body 15Biliary Tract Neoplasms 15Small Cell Lung Carcinoma 14Esophageal Squamous Cell Carcinoma 14Uterine Cervical Neoplasms 13Neoplasms 13Neoplasm Metastasis 13Cholangiocarcinoma 13Ovarian Neoplasms 12Colorectal Neoplasms 12Pancreatic Neoplasms 11Carcinoma, Squamous Cell 11Laryngeal Neoplasms 10Stomach Neoplasms 9Mouth Neoplasms 9Endometrial Neoplasms 9Gallbladder Neoplasms 8Carcinoma, Transitional Cell 8Hypopharyngeal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Mesothelioma, Malignant 6

Interventions

Immunotherapy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Carcinoma × Cisplatin × 90 days × Clear all
NCT07613567 2026-05-29

A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer

Fujian Cancer Hospital

Phase 3 Not yet recruiting
486 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡